STOCKSCREENR

0RU5.L

LSE

Oncoinvent ASA

$49.50+1.50(+3.13%)Mkt Cap: $1.94B

Key Stats

Market Cap

$1.94B

P/E Ratio

-14.13

EPS

$-3.50

Dividend Yield

0.00%

52-Week Range

$0.08 — $49.50

Volume

88

Avg Volume

238.76K

Beta

1.31

Price Alerts for 0RU5.L

Get alerted when 0RU5.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-14.13

Forward P/E

—

PEG Ratio

-0.18

P/S (TTM)

39.94

P/B (TTM)

28.12

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-1.13%

ROA (TTM)

-1.24%

ROIC

—

Gross Margin

0.98%

Operating Margin

-21.33%

Net Margin

—

Debt/Equity

0.00

Current Ratio

4.39

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

+0.46%

EPS Growth (5Y)

+0.27%

Sales Growth (3Y)

+0.27%

Sales Growth (5Y)

+0.03%

EPS Est (This Year)

$-0.04

EPS Est (Next Year)

$-0.04

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$1.69

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

39.09M

Float

25.58M

Free Float %

65.42%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

NO

Exchange

LSE

IPO Date

2017-12-13

Employees

36

CEO

Oystein Soug

Index Membership

—

Website

https://www.oncoinvent.com

Oncoinvent ASA (0RU5.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $1.94B, a P/E ratio of -14.13, 0RU5.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0RU5.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

ATAI

Atai Beckley N.V

$4.16

+0.97%

$784.68M

0J2O.L

Halozyme Therapeutics, Inc.

$64.11

+1.60%

$7.57B

0RA9.L

Abivax S.A.

$92.20

-0.59%

$7.30B

0QND.L

Bachem Holding AG

$70.06

+2.29%

$5.24B

0L35.L

Sarepta Therapeutics, Inc.

$21.09

+2.59%

$2.11B

0IMT.L

Photocure ASA

$65.10

-4.41%

$1.73B

Frequently Asked Questions

What is Oncoinvent ASA's P/E ratio?

Oncoinvent ASA (0RU5.L) has a trailing twelve-month (TTM) P/E ratio of -14.13. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Oncoinvent ASA pay a dividend?

No, Oncoinvent ASA (0RU5.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Oncoinvent ASA's market cap?

Oncoinvent ASA (0RU5.L) has a market capitalization of $1.94 billion, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.